CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 49 enrolled
Drug / intervention
remote pulmonary function testing +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03214224
NCT03214224N/ACompleted
CompareCT.gov

Remote Pulmonary Function Testing in Amyotrophic Lateral Sclerosis (Pilot)

Milton S. Hershey Medical Center·interventional·Posted Jul 11, 2017·Updated Aug 7, 2020

In Brief

A clinical study evaluating remote pulmonary function testing and standard pulmonary function testing for ALS. Completed, enrolled 49 participants across 1 site.

Detailed Summary

The specific objective of this study is to validate the practice of remote pulmonary function testing (rPFT) conducted in the home through the use of connected mobile health devices and the Penn State Hershey ALS Telemanagement program.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsALS
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJul 11, 2017
Enrollment StartNov 1, 2017
Primary CompletionSep 30, 2019
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 9.0 years ago

Interventions

remote pulmonary function testingdevice

Telemedicine delivery of pulmonary function testing in ALS, including Forced Vital Capacity (FVC) and Maximal Inspiratory Pressure (MIP)

standard pulmonary function testingdevice

Standard clinical delivery of pulmonary function testing in ALS, including Forced Vital Capacity (FVC) and Maximal Inspiratory Pressure (MIP)